Company location
Tokyo, Japan
TAKEDA PHARMACEUTICAL CO LTD has filed 676 SEC EDGAR filings since 05 Mar 2007

SEC filing history

Showing 651-662 of 662 matching filings.

Per page
25
Current page
27
SC TO-T/A

AMENDMENT NO. 4 TO SC TO-T

Filing date
08 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

AMENDMENT NO. 3 TO SC TO-T

Filing date
02 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

AMENDMENT NO. 2 TO SC TO-T

Filing date
30 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
24 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T

SC TO-T

Filing date
19 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D

SC 13D

Filing date
18 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
11 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
10 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
09 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G filing

Filing date
28 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-166263

EFFECT filing

Filing date
10 May 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-6 File 333-166263

FORM F-6

Filing date
23 Apr 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .